Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026)

Sight Sciences (SGHT) recorded quarterly Net Income towards Common Stockholders of -$13.0 million in Q1 2026, down 211.87% quarter-over-quarter from -$4.2 million in Q4 2025, and up 8.29% on a YoY basis from -$12.0 million in Q1 2025.

Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Sight Sciences' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$13.0 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 8.29% year-over-year to -$13.0 million; the TTM figure through Mar 2026 stood at -$37.3 million (up 24.58% YoY), while the FY2025 annual figure was -$38.4 million, up 25.4% from the prior year.
  • Net Income towards Common Stockholders was -$13.0 million for Q1 2026 at Sight Sciences, down from -$4.2 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$4.2 million in Q4 2025 to a low of -$23.8 million in Q2 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$14.4 million across 5 years, with a median of -$13.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders slumped 90.06% in 2022, then jumped 64.87% in 2025.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$16.9 million in 2022, then soared by 36.77% to -$10.7 million in 2023, then fell by 10.8% to -$11.8 million in 2024, then surged by 64.87% to -$4.2 million in 2025, then tumbled by 211.87% to -$13.0 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$13.0 million (Q1 2026), -$4.2 million (Q4 2025), and -$8.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.08 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 745.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 411.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 187,319.30
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 199.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -
10 Sight Sciences 274.57 Mn 189.61 Mn 16.98 Mn -12.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.98 Mn
Dec 31, 2025 -4.16 Mn
Sep 30, 2025 -8.17 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -14.15 Mn
Dec 31, 2024 -11.85 Mn
Sep 30, 2024 -11.07 Mn
Jun 30, 2024 -12.33 Mn
Mar 31, 2024 -16.27 Mn
Dec 31, 2023 -10.69 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -14.75 Mn
Mar 31, 2023 -17.07 Mn
Dec 31, 2022 -16.91 Mn
Sep 30, 2022 -22.23 Mn
Jun 30, 2022 -23.84 Mn
Mar 31, 2022 -23.26 Mn
Dec 31, 2021 -15.94 Mn
Sep 30, 2021 -17.17 Mn
Jun 30, 2021 -17.62 Mn